Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1968 May;60(1):206–213. doi: 10.1073/pnas.60.1.206

Psychedelic drugs: steric factors that predict psychotropic activity.

S H Snyder, E Richelson
PMCID: PMC539103  PMID: 5241523

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BALESTRIERI A., FONTANARI D. Acquired and crossed tolerance to mescaline, LSD-25, and BOL-148. AMA Arch Gen Psychiatry. 1959 Sep;1:279–282. doi: 10.1001/archpsyc.1959.03590030063008. [DOI] [PubMed] [Google Scholar]
  2. BRENTANI M., BRENTANI R., RAW I. ROLE OF NUCLEOLAR RIBONUCLEIC ACID IN INCORPORATION OF RIBOSOMAL AMINO ACID. Nature. 1964 Mar 14;201:1130–1130. doi: 10.1038/2011130a0. [DOI] [PubMed] [Google Scholar]
  3. GIARMAN N. J., FREEDMAN D. X. BIOCHEMICAL ASPECTS OF THE ACTIONS OF PSYCHOTOMIMETIC DRUGS. Pharmacol Rev. 1965 Mar;17:1–25. [PubMed] [Google Scholar]
  4. ISBELL H., WOLBACH A. B., WIKLER A., MINER E. J. Cross tolerance between LSD and psilocybin. Psychopharmacologia. 1961;2:147–159. doi: 10.1007/BF00407974. [DOI] [PubMed] [Google Scholar]
  5. Sargent T. W., Israelstam D. M., Shulgin A. T., Landaw S. A., Finley N. N. A note concerning the fate of the 4-methoxyl group in 3, 4-dimethoxyphenethylamine (DMPEA). Biochem Biophys Res Commun. 1967 Oct 11;29(1):126–130. doi: 10.1016/0006-291x(67)90552-9. [DOI] [PubMed] [Google Scholar]
  6. Schweitzer J. W., Friedhoff A. J. The metabolism of alpha-14C-3,4-dimethoxyphenethylamine. Biochem Pharmacol. 1966 Dec;15(12):2097–2103. doi: 10.1016/0006-2952(66)90239-5. [DOI] [PubMed] [Google Scholar]
  7. Shulgin A. T. Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines. Experientia. 1964 Jul 15;20(7):366–367. doi: 10.1007/BF02147960. [DOI] [PubMed] [Google Scholar]
  8. Shulgin A. T., Sargent T. Psychotrophic phenylisopropylamines derived from apiole and dillapiole. Nature. 1967 Sep 30;215(5109):1494–1495. doi: 10.1038/2151494b0. [DOI] [PubMed] [Google Scholar]
  9. Shulgin A. T. The six trimethoxyphenylisopropylamines (trimethoxyamphetamines). J Med Chem. 1966 May;9(3):445–446. doi: 10.1021/jm00321a058. [DOI] [PubMed] [Google Scholar]
  10. Smythies J. R., Johnston V. S., Bradley R. J., Benington F., Morin R. D., Clark L. C. Some new behaviour-disrupting amphetamines and their significance. Nature. 1967 Oct 14;216(5111):128–129. doi: 10.1038/216128a0. [DOI] [PubMed] [Google Scholar]
  11. Snyder S. H., Faillace L., Hollister L. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug. Science. 1967 Nov 3;158(3801):669–670. doi: 10.1126/science.158.3801.669. [DOI] [PubMed] [Google Scholar]
  12. Snyder S. H., Merril C. R. A relationship between the hallucinogenic activity of drugs and their electronic configuration. Proc Natl Acad Sci U S A. 1965 Jul;54(1):258–266. doi: 10.1073/pnas.54.1.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. TURNER W. J., MERLIS S. Effect of some indolealkylamines on man. AMA Arch Neurol Psychiatry. 1959 Jan;81(1):121–129. doi: 10.1001/archneurpsyc.1959.02340130141020. [DOI] [PubMed] [Google Scholar]
  14. Uyeno E. T. Hallucinogenic compounds and swimming response. J Pharmacol Exp Ther. 1968 Jan;159(1):216–221. [PubMed] [Google Scholar]
  15. WOLBACH A. B., Jr, MINER E. J., ISBELL H. Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia. 1962;3:219–223. doi: 10.1007/BF00412109. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES